nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Vincristine—peripheral nervous system neoplasm	0.143	0.198	CbGbCtD
Gadoxetate—ABCC3—Cisplatin—peripheral nervous system neoplasm	0.133	0.185	CbGbCtD
Gadoxetate—ABCC3—Etoposide—peripheral nervous system neoplasm	0.131	0.181	CbGbCtD
Gadoxetate—ABCC3—Doxorubicin—peripheral nervous system neoplasm	0.0894	0.124	CbGbCtD
Gadoxetate—ABCC2—Vincristine—peripheral nervous system neoplasm	0.065	0.0899	CbGbCtD
Gadoxetate—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.0607	0.0839	CbGbCtD
Gadoxetate—ABCC2—Etoposide—peripheral nervous system neoplasm	0.0596	0.0824	CbGbCtD
Gadoxetate—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0406	0.0562	CbGbCtD
Gadoxetate—ABCC3—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.00114	0.0814	CbGpPWpGaD
Gadoxetate—ABCC2—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000906	0.0645	CbGpPWpGaD
Gadoxetate—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000851	0.0606	CbGpPWpGaD
Gadoxetate—ABCC2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000769	0.0547	CbGpPWpGaD
Gadoxetate—SLCO1B1—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000722	0.0514	CbGpPWpGaD
Gadoxetate—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000625	0.0445	CbGpPWpGaD
Gadoxetate—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000588	0.0419	CbGpPWpGaD
Gadoxetate—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000496	0.0353	CbGpPWpGaD
Gadoxetate—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000465	0.0331	CbGpPWpGaD
Gadoxetate—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000377	0.0268	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000359	0.0256	CbGpPWpGaD
Gadoxetate—ABCC3—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000343	0.0244	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—NF2—peripheral nervous system neoplasm	0.000336	0.0239	CbGpPWpGaD
Gadoxetate—ABCC4—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000322	0.023	CbGpPWpGaD
Gadoxetate—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000299	0.0213	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000285	0.0203	CbGpPWpGaD
Gadoxetate—ABCC2—ABC-family proteins mediated transport—ABCB1—peripheral nervous system neoplasm	0.000272	0.0194	CbGpPWpGaD
Gadoxetate—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000205	0.000781	CcSEcCtD
Gadoxetate—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000205	0.00078	CcSEcCtD
Gadoxetate—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000205	0.00078	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000779	CcSEcCtD
Gadoxetate—Infection—Cisplatin—peripheral nervous system neoplasm	0.000204	0.000775	CcSEcCtD
Gadoxetate—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000204	0.000774	CcSEcCtD
Gadoxetate—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000202	0.00077	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00077	CcSEcCtD
Gadoxetate—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000202	0.000768	CcSEcCtD
Gadoxetate—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000202	0.000768	CcSEcCtD
Gadoxetate—Rash—Topotecan—peripheral nervous system neoplasm	0.000202	0.000768	CcSEcCtD
Gadoxetate—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000202	0.000767	CcSEcCtD
Gadoxetate—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000202	0.000767	CcSEcCtD
Gadoxetate—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000201	0.000765	CcSEcCtD
Gadoxetate—Cough—Etoposide—peripheral nervous system neoplasm	0.000201	0.000764	CcSEcCtD
Gadoxetate—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000764	CcSEcCtD
Gadoxetate—Headache—Topotecan—peripheral nervous system neoplasm	0.000201	0.000763	CcSEcCtD
Gadoxetate—Rash—Tretinoin—peripheral nervous system neoplasm	0.0002	0.000762	CcSEcCtD
Gadoxetate—Rash—Isotretinoin—peripheral nervous system neoplasm	0.0002	0.000762	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.0002	0.000762	CcSEcCtD
Gadoxetate—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.0002	0.000761	CcSEcCtD
Gadoxetate—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.0002	0.000761	CcSEcCtD
Gadoxetate—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.0002	0.000761	CcSEcCtD
Gadoxetate—Fatigue—Vincristine—peripheral nervous system neoplasm	0.0002	0.000761	CcSEcCtD
Gadoxetate—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000199	0.000759	CcSEcCtD
Gadoxetate—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000199	0.000758	CcSEcCtD
Gadoxetate—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000758	CcSEcCtD
Gadoxetate—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000199	0.000758	CcSEcCtD
Gadoxetate—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000199	0.000757	CcSEcCtD
Gadoxetate—Headache—Tretinoin—peripheral nervous system neoplasm	0.000199	0.000757	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000198	0.0141	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.000754	CcSEcCtD
Gadoxetate—Constipation—Vincristine—peripheral nervous system neoplasm	0.000198	0.000754	CcSEcCtD
Gadoxetate—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000198	0.000754	CcSEcCtD
Gadoxetate—Rash—Melphalan—peripheral nervous system neoplasm	0.000198	0.000752	CcSEcCtD
Gadoxetate—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000197	0.000751	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000749	CcSEcCtD
Gadoxetate—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000196	0.000746	CcSEcCtD
Gadoxetate—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000195	0.000744	CcSEcCtD
Gadoxetate—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000742	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000195	0.00074	CcSEcCtD
Gadoxetate—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000194	0.000737	CcSEcCtD
Gadoxetate—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000192	0.000729	CcSEcCtD
Gadoxetate—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000728	CcSEcCtD
Gadoxetate—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000191	0.000728	CcSEcCtD
Gadoxetate—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000191	0.000727	CcSEcCtD
Gadoxetate—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.000724	CcSEcCtD
Gadoxetate—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00019	0.000724	CcSEcCtD
Gadoxetate—Nausea—Topotecan—peripheral nervous system neoplasm	0.00019	0.000723	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.00019	0.000721	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000189	0.0135	CbGpPWpGaD
Gadoxetate—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000189	0.000718	CcSEcCtD
Gadoxetate—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000189	0.000718	CcSEcCtD
Gadoxetate—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000188	0.000715	CcSEcCtD
Gadoxetate—Infection—Etoposide—peripheral nervous system neoplasm	0.000187	0.00071	CcSEcCtD
Gadoxetate—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000709	CcSEcCtD
Gadoxetate—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.000708	CcSEcCtD
Gadoxetate—Nausea—Melphalan—peripheral nervous system neoplasm	0.000186	0.000708	CcSEcCtD
Gadoxetate—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000707	CcSEcCtD
Gadoxetate—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000185	0.000704	CcSEcCtD
Gadoxetate—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000701	CcSEcCtD
Gadoxetate—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000184	0.0007	CcSEcCtD
Gadoxetate—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000183	0.000697	CcSEcCtD
Gadoxetate—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000183	0.000697	CcSEcCtD
Gadoxetate—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000183	0.000697	CcSEcCtD
Gadoxetate—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000183	0.000695	CcSEcCtD
Gadoxetate—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000182	0.000694	CcSEcCtD
Gadoxetate—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000182	0.000691	CcSEcCtD
Gadoxetate—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000686	CcSEcCtD
Gadoxetate—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000179	0.000681	CcSEcCtD
Gadoxetate—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000178	0.000678	CcSEcCtD
Gadoxetate—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000677	CcSEcCtD
Gadoxetate—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000178	0.000676	CcSEcCtD
Gadoxetate—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000675	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000177	0.000673	CcSEcCtD
Gadoxetate—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000176	0.000668	CcSEcCtD
Gadoxetate—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000657	CcSEcCtD
Gadoxetate—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000656	CcSEcCtD
Gadoxetate—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000652	CcSEcCtD
Gadoxetate—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000171	0.00065	CcSEcCtD
Gadoxetate—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00017	0.000648	CcSEcCtD
Gadoxetate—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000643	CcSEcCtD
Gadoxetate—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000169	0.000642	CcSEcCtD
Gadoxetate—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000167	0.000637	CcSEcCtD
Gadoxetate—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000166	0.000633	CcSEcCtD
Gadoxetate—ABCC4—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.000165	0.0118	CbGpPWpGaD
Gadoxetate—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000165	0.000628	CcSEcCtD
Gadoxetate—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000627	CcSEcCtD
Gadoxetate—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000165	0.000626	CcSEcCtD
Gadoxetate—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000164	0.000623	CcSEcCtD
Gadoxetate—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000163	0.000621	CcSEcCtD
Gadoxetate—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000617	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000162	0.000617	CcSEcCtD
Gadoxetate—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000162	0.000617	CcSEcCtD
Gadoxetate—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000162	0.000616	CcSEcCtD
Gadoxetate—Constipation—Etoposide—peripheral nervous system neoplasm	0.000161	0.000611	CcSEcCtD
Gadoxetate—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000611	CcSEcCtD
Gadoxetate—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000159	0.000605	CcSEcCtD
Gadoxetate—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000159	0.000604	CcSEcCtD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.000157	0.0112	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000155	0.000589	CcSEcCtD
Gadoxetate—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000154	0.000587	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000154	0.000584	CcSEcCtD
Gadoxetate—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000153	0.000583	CcSEcCtD
Gadoxetate—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000582	CcSEcCtD
Gadoxetate—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000577	CcSEcCtD
Gadoxetate—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000577	CcSEcCtD
Gadoxetate—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000575	CcSEcCtD
Gadoxetate—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000574	CcSEcCtD
Gadoxetate—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000571	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.00015	0.0107	CbGpPWpGaD
Gadoxetate—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000149	0.000568	CcSEcCtD
Gadoxetate—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000565	CcSEcCtD
Gadoxetate—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000149	0.000565	CcSEcCtD
Gadoxetate—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000149	0.000565	CcSEcCtD
Gadoxetate—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000565	CcSEcCtD
Gadoxetate—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000561	CcSEcCtD
Gadoxetate—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000147	0.000561	CcSEcCtD
Gadoxetate—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000147	0.00056	CcSEcCtD
Gadoxetate—Rash—Vincristine—peripheral nervous system neoplasm	0.000146	0.000556	CcSEcCtD
Gadoxetate—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000146	0.000556	CcSEcCtD
Gadoxetate—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000146	0.000554	CcSEcCtD
Gadoxetate—Headache—Vincristine—peripheral nervous system neoplasm	0.000145	0.000553	CcSEcCtD
Gadoxetate—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.000544	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000142	0.0101	CbGpPWpGaD
Gadoxetate—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00014	0.000534	CcSEcCtD
Gadoxetate—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000138	0.000527	CcSEcCtD
Gadoxetate—Nausea—Vincristine—peripheral nervous system neoplasm	0.000138	0.000524	CcSEcCtD
Gadoxetate—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000523	CcSEcCtD
Gadoxetate—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000523	CcSEcCtD
Gadoxetate—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000523	CcSEcCtD
Gadoxetate—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000519	CcSEcCtD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000135	0.00963	CbGpPWpGaD
Gadoxetate—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000135	0.000513	CcSEcCtD
Gadoxetate—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000135	0.000513	CcSEcCtD
Gadoxetate—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000512	CcSEcCtD
Gadoxetate—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000509	CcSEcCtD
Gadoxetate—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000508	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000133	0.00949	CbGpPWpGaD
Gadoxetate—Chills—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000506	CcSEcCtD
Gadoxetate—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000133	0.000506	CcSEcCtD
Gadoxetate—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000504	CcSEcCtD
Gadoxetate—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000496	CcSEcCtD
Gadoxetate—Rash—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000492	CcSEcCtD
Gadoxetate—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000491	CcSEcCtD
Gadoxetate—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000129	0.000489	CcSEcCtD
Gadoxetate—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000484	CcSEcCtD
Gadoxetate—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000484	CcSEcCtD
Gadoxetate—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000484	CcSEcCtD
Gadoxetate—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000481	CcSEcCtD
Gadoxetate—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000475	CcSEcCtD
Gadoxetate—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000473	CcSEcCtD
Gadoxetate—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000124	0.000473	CcSEcCtD
Gadoxetate—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000471	CcSEcCtD
Gadoxetate—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.00047	CcSEcCtD
Gadoxetate—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000468	CcSEcCtD
Gadoxetate—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000466	CcSEcCtD
Gadoxetate—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000122	0.000463	CcSEcCtD
Gadoxetate—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000463	CcSEcCtD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00012	0.00853	CbGpPWpGaD
Gadoxetate—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.00012	0.000455	CcSEcCtD
Gadoxetate—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000119	0.000454	CcSEcCtD
Gadoxetate—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000451	CcSEcCtD
Gadoxetate—Rash—Etoposide—peripheral nervous system neoplasm	0.000118	0.000451	CcSEcCtD
Gadoxetate—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000118	0.00045	CcSEcCtD
Gadoxetate—Headache—Etoposide—peripheral nervous system neoplasm	0.000118	0.000448	CcSEcCtD
Gadoxetate—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000448	CcSEcCtD
Gadoxetate—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000445	CcSEcCtD
Gadoxetate—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000443	CcSEcCtD
Gadoxetate—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000441	CcSEcCtD
Gadoxetate—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00044	CcSEcCtD
Gadoxetate—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000439	CcSEcCtD
Gadoxetate—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000434	CcSEcCtD
Gadoxetate—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000431	CcSEcCtD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000113	0.00802	CbGpPWpGaD
Gadoxetate—Cough—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000428	CcSEcCtD
Gadoxetate—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000428	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000112	0.008	CbGpPWpGaD
Gadoxetate—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000425	CcSEcCtD
Gadoxetate—Nausea—Etoposide—peripheral nervous system neoplasm	0.000112	0.000425	CcSEcCtD
Gadoxetate—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000421	CcSEcCtD
Gadoxetate—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000418	CcSEcCtD
Gadoxetate—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000417	CcSEcCtD
Gadoxetate—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000416	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000415	CcSEcCtD
Gadoxetate—ABCC3—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000109	0.00774	CbGpPWpGaD
Gadoxetate—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000413	CcSEcCtD
Gadoxetate—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00041	CcSEcCtD
Gadoxetate—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000409	CcSEcCtD
Gadoxetate—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000408	CcSEcCtD
Gadoxetate—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000407	CcSEcCtD
Gadoxetate—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000401	CcSEcCtD
Gadoxetate—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000401	CcSEcCtD
Gadoxetate—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000401	CcSEcCtD
Gadoxetate—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000399	CcSEcCtD
Gadoxetate—Infection—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000398	CcSEcCtD
Gadoxetate—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000396	CcSEcCtD
Gadoxetate—Shock—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000394	CcSEcCtD
Gadoxetate—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000394	CcSEcCtD
Gadoxetate—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000393	CcSEcCtD
Gadoxetate—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000391	CcSEcCtD
Gadoxetate—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000389	CcSEcCtD
Gadoxetate—ABCC4—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000102	0.00727	CbGpPWpGaD
Gadoxetate—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000387	CcSEcCtD
Gadoxetate—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000387	CcSEcCtD
Gadoxetate—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000385	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000384	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000101	0.00717	CbGpPWpGaD
Gadoxetate—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000382	CcSEcCtD
Gadoxetate—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000382	CcSEcCtD
Gadoxetate—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	9.94e-05	0.000378	CcSEcCtD
Gadoxetate—SLCO1B3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	9.9e-05	0.00705	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.88e-05	0.00704	CbGpPWpGaD
Gadoxetate—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.84e-05	0.000374	CcSEcCtD
Gadoxetate—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000371	CcSEcCtD
Gadoxetate—Oedema—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000371	CcSEcCtD
Gadoxetate—Infection—Doxorubicin—peripheral nervous system neoplasm	9.68e-05	0.000368	CcSEcCtD
Gadoxetate—Shock—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000365	CcSEcCtD
Gadoxetate—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.56e-05	0.000364	CcSEcCtD
Gadoxetate—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000362	CcSEcCtD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.51e-05	0.00677	CbGpPWpGaD
Gadoxetate—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.46e-05	0.00036	CcSEcCtD
Gadoxetate—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.46e-05	0.00036	CcSEcCtD
Gadoxetate—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000358	CcSEcCtD
Gadoxetate—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.39e-05	0.000357	CcSEcCtD
Gadoxetate—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.29e-05	0.000353	CcSEcCtD
Gadoxetate—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.000348	CcSEcCtD
Gadoxetate—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.1e-05	0.000346	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.09e-05	0.000346	CcSEcCtD
Gadoxetate—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000345	CcSEcCtD
Gadoxetate—Constipation—Epirubicin—peripheral nervous system neoplasm	9e-05	0.000343	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.91e-05	0.00635	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	8.8e-05	0.00627	CbGpPWpGaD
Gadoxetate—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.75e-05	0.000333	CcSEcCtD
Gadoxetate—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.69e-05	0.00033	CcSEcCtD
Gadoxetate—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.00033	CcSEcCtD
Gadoxetate—ABCC2—NRF2 pathway—HGF—peripheral nervous system neoplasm	8.61e-05	0.00613	CbGpPWpGaD
Gadoxetate—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000328	CcSEcCtD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.58e-05	0.00611	CbGpPWpGaD
Gadoxetate—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000322	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.41e-05	0.00032	CcSEcCtD
Gadoxetate—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.00032	CcSEcCtD
Gadoxetate—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.37e-05	0.000318	CcSEcCtD
Gadoxetate—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.33e-05	0.000317	CcSEcCtD
Gadoxetate—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000317	CcSEcCtD
Gadoxetate—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.32e-05	0.000317	CcSEcCtD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.07e-05	0.00574	CbGpPWpGaD
Gadoxetate—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000305	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000303	CcSEcCtD
Gadoxetate—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.76e-05	0.000295	CcSEcCtD
Gadoxetate—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.74e-05	0.000294	CcSEcCtD
Gadoxetate—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000293	CcSEcCtD
Gadoxetate—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.7e-05	0.000293	CcSEcCtD
Gadoxetate—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000287	CcSEcCtD
Gadoxetate—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000283	CcSEcCtD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	7.33e-05	0.00522	CbGpPWpGaD
Gadoxetate—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000274	CcSEcCtD
Gadoxetate—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000273	CcSEcCtD
Gadoxetate—Asthenia—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000266	CcSEcCtD
Gadoxetate—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.96e-05	0.000265	CcSEcCtD
Gadoxetate—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000262	CcSEcCtD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.8e-05	0.00484	CbGpPWpGaD
Gadoxetate—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000255	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.67e-05	0.00475	CbGpPWpGaD
Gadoxetate—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.67e-05	0.000254	CcSEcCtD
Gadoxetate—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.65e-05	0.00474	CbGpPWpGaD
Gadoxetate—Rash—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000253	CcSEcCtD
Gadoxetate—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.64e-05	0.00473	CbGpPWpGaD
Gadoxetate—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000252	CcSEcCtD
Gadoxetate—Headache—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000251	CcSEcCtD
Gadoxetate—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.44e-05	0.000245	CcSEcCtD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.39e-05	0.00455	CbGpPWpGaD
Gadoxetate—Nausea—Epirubicin—peripheral nervous system neoplasm	6.25e-05	0.000238	CcSEcCtD
Gadoxetate—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000236	CcSEcCtD
Gadoxetate—Rash—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000234	CcSEcCtD
Gadoxetate—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000233	CcSEcCtD
Gadoxetate—Headache—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000232	CcSEcCtD
Gadoxetate—ABCC3—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.02e-05	0.00429	CbGpPWpGaD
Gadoxetate—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.00022	CcSEcCtD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.55e-05	0.00395	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.03e-05	0.00358	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5e-05	0.00356	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—IFNB1—peripheral nervous system neoplasm	4.89e-05	0.00349	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	4.83e-05	0.00344	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	4.63e-05	0.00329	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.54e-05	0.00323	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KNG1—peripheral nervous system neoplasm	4.54e-05	0.00323	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.48e-05	0.00319	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	4.45e-05	0.00317	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	4.37e-05	0.00311	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GNS—peripheral nervous system neoplasm	4.35e-05	0.0031	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.27e-05	0.00304	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—NME1—peripheral nervous system neoplasm	4.17e-05	0.00297	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.05e-05	0.00288	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—COX2—peripheral nervous system neoplasm	4.02e-05	0.00286	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.97e-05	0.00283	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—GNAS—peripheral nervous system neoplasm	3.97e-05	0.00282	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HGF—peripheral nervous system neoplasm	3.78e-05	0.00269	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.73e-05	0.00265	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.65e-05	0.0026	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.6e-05	0.00256	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.58e-05	0.00255	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.43e-05	0.00245	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.38e-05	0.00241	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.37e-05	0.0024	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	3.24e-05	0.00231	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	3.11e-05	0.00221	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	2.99e-05	0.00213	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	2.92e-05	0.00208	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.9e-05	0.00206	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.84e-05	0.00202	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PTPN11—peripheral nervous system neoplasm	2.76e-05	0.00196	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.72e-05	0.00194	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.67e-05	0.0019	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ENO2—peripheral nervous system neoplasm	2.64e-05	0.00188	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	2.47e-05	0.00176	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.36e-05	0.00168	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	2.32e-05	0.00165	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—BCHE—peripheral nervous system neoplasm	2.23e-05	0.00159	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.13e-05	0.00151	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TH—peripheral nervous system neoplasm	2.1e-05	0.00149	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	2.08e-05	0.00148	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.96e-05	0.0014	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	1.9e-05	0.00135	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.86e-05	0.00132	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—GNAS—peripheral nervous system neoplasm	1.71e-05	0.00122	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.68e-05	0.0012	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.66e-05	0.00118	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NRAS—peripheral nervous system neoplasm	1.66e-05	0.00118	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.58e-05	0.00113	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.56e-05	0.00111	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000907	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—peripheral nervous system neoplasm	1.27e-05	0.000903	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.25e-05	0.00089	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HRAS—peripheral nervous system neoplasm	1.21e-05	0.000864	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—peripheral nervous system neoplasm	1.07e-05	0.000762	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	5.12e-06	0.000364	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—peripheral nervous system neoplasm	4.62e-06	0.000329	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	3.44e-06	0.000245	CbGpPWpGaD
